Peak Bio Announces CEO Transition and New Leadership
Company Announcements

Peak Bio Announces CEO Transition and New Leadership

An update from Peak Bio (PKBO) is now available.

Stephen LaMond has stepped down as the Interim CEO and COO of Peak Bio, Inc., and will transition to a consulting role to aid in handing over to new management. His departure is coupled with a separation agreement that includes a consulting fee and stock options, while Hoyoung Huh will take over CEO duties effective immediately. LaMond’s agreement includes financial compensation and benefits, ensuring a smooth management transition.

For an in-depth examination of PKBO stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyAkari Therapeutics announces effectiveness of Form S-4 related to merger
TipRanks Auto-Generated NewsdeskPeak Bio Incentivizes Leadership with Stock Options for Growth
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App